ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting [clear]
Client Age [clear]
Topic Area [clear]
Experience
Course Format
SIG
Instructional Level
Results 11 - 20 of 65
Presenter(s): Rene L Utianski, PhD, CCC-SLP, BC-ANCDS; Kristie A Spencer, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Motor speech disorders occur secondary to a wide variety of progressive neurological disorders. This course discusses strategies for the speaker, listener, and environment that clinicians can consider for managing progressive motor speech disorders. Presenters discuss management strategies in the context of concomitant decline of cognitive-linguistic and motoric function from neurodegenerative processes.
Presenter(s): Maja Katusic, MD; Kelly Brytowski, MA, CCC-SLP; Becky S Baas, MA, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This course explores the common journeys children with motor speech disorders and their families undertake when seeking diagnosis and treatment. The speakers discuss the medical workup, the role of expert SLPs, and the partnerships among the medical and educational teams serving children.
Presenter(s): Jennifer Gray, MS, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: Down syndrome is a genetic syndrome characterized by unique anatomical and physiological traits; medical complications affecting movement, respiration, feeding, and metabolism; intellectual disabilities; as well as dysarthria and other communication challenges. This on demand webinar shares evidence-based techniques that target motor speech, voice, fluency, and functional language to maximize intelligibility and comprehensibility of speech and language for individuals with Down syndrome.
Credit(s): PDHs: 3.5, ASHA CEUs*: 0.35
Summary: This SIG 19 activity bundles four articles providing perspectives on a broad variety of topics in speech-language pathology. First, Holt provides an overview of current and historical discussions of gender and race, challenging the reader to accept that one’s perspective is indebted to a specific belief system. Readers are to evaluate how gender and race are used to categorize people and examine whether a member of a marginalized or minoritized group affects that person’s access to or use of intervention services. Next, Cox and Koenig define speech privacy and provide a brief history and applications in the health care setting. A general perspective is outlined, including threats to speech privacy, and speakers who use an electrolarynx are used as an example to highlight specific issues clinicians may encounter. Ramanarayanan et al. discuss the use of speech as a biomarker in therapy and research. In summary, robustness of analytics—specificity, diversity, and physiological interpretability—must be further developed. Finally, Weerathunge, Tomassi, and Stepp review a number of populations with voice disorders that have been studied using altered auditory feedback. Many have hyperactive auditory feedback responses and the differing underling reasons are reviewed. Therapy considerations are also described.
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: It is well known within our field that identifying voice and upper airway specialized training opportunities and subsequent positions is challenging, competitive, and sometimes elusive. In this SIG 3 activity, various pathways to specializing in voice and upper airway disorders are explored from the viewpoint of different authors at various stages of their careers. The hope is to make the process of specialization more transparent and share components that have contributed to success, while also highlighting the diversity of training and experience that is so important in our field.
Credit(s): PDHs: 6.5, ASHA CEUs*: 0.65
Summary: The articles in this journal self-study focus on the characterization and clinical management of aphasia, one theme that researchers explored in the 2020 Clinical Aphasiology Conference (CAC) forum. Published in the American Journal of Speech-Language Pathology, these articles present cutting-edge research and discussion on word finding difficulties, sematic processing, and spoken discourse.
Presenter(s): Ashwini M. Namasivayam-MacDonald, PhD, CCC-SLP, SLP(C)
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This on demand webinar focuses on identification and management of dysphagia in people with dementia, with discussion of current research on dysphagia assessment, intervention, and caregiver burden. The webinar presents preferred practices for maximizing quality of life for this patient population.
Credit(s): PDHs: 3.5, ASHA CEUs*: 0.35
Summary: This SIG 5 activity analyzes the relationship between the opioid crisis and cleft lip and palate care across the life span. Two main themes of prevention and treatment after exposure are explained. The articles outline alternatives to opioid use after cleft-related surgeries, impacts on infants and children who were exposed in utero, and velopharyngeal insufficiency treatment after substance abuse.
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Rebecca J Boersma, MA, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session reviews the emerging evidence of neurological manifestations of COVID-19 and identifies how SLPs can use their unique position to maximize patient outcomes-whether as a member of an interdisciplinary team or as a solo provider. The session strives to increase clinicians' confidence in their abilities to: identify common cognitive-communication symptoms for patients who have recovered from COVID-19, and evaluate and treat with an individualized, patient-centered approach.
<< 1 2 3 4 5 6 7 >>